MoneyWorks4Me

Sanofi India - Quaterly Results

03 Nov 2022 Evaluate
A decrease in the sales to Rs. 6919.00 millions was observed for the quarter ended September 2022. The sales stood at Rs. 7545.00 millions during the similar quarter previous year.The company suffered a huge decline of -75.29% to Rs. 1309.00  millions from Rs. 5298.00 millions  of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 1933.00 millions from 2135.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202112 202012 % Var
Sales 6919.00 7545.00 -8.30 20982.00 22687.00 -7.52 29566.00 29019.00 1.88
Other Income 114.00 147.00 -22.45 515.00 581.00 -11.36 744.00 898.00 -17.15
PBIDT 1933.00 2135.00 -9.46 5890.00 6934.00 -15.06 8369.00 8029.00 4.23
Interest 5.00 5.00 0.00 13.00 14.00 -7.14 18.00 18.00 0.00
PBDT 1928.00 7022.00 -72.54 7058.00 11812.00 -40.25 13243.00 7594.00 74.39
Depreciation 104.00 143.00 -27.27 319.00 558.00 -42.83 667.00 822.00 -18.86
PBT 1824.00 6879.00 -73.48 6739.00 11254.00 -40.12 12576.00 6772.00 85.71
TAX 515.00 1581.00 -67.43 1842.00 2714.00 -32.13 3132.00 1996.00 56.91
Deferred Tax -12.00 -133.00 -90.98 20.00 -216.00 -109.26 -228.00 -114.00 100.00
PAT 1309.00 5298.00 -75.29 4897.00 8540.00 -42.66 9444.00 4776.00 97.74
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 27.94 28.30 -1.27 28.07 30.56 -8.15 28.31 27.67 2.31
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..